Mersana Therapeutics, Inc. total revenue, net income and dynamics of changes in Euro today
The dynamics of Mersana Therapeutics, Inc. net revenue grew by 0 € compared to the previous report. The dynamics of net income of Mersana Therapeutics, Inc. has changed by -6 220 000 € in recent years. Here are the main financial indicators of Mersana Therapeutics, Inc.. Mersana Therapeutics, Inc. net income is shown in blue on the graph. All information on Mersana Therapeutics, Inc. total revenue on this chart is created in the form of yellow bars. The value of Mersana Therapeutics, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
10 273.80 €
-94.554 % ↓
-38 212 005.57 €
-
31/03/2021
10 273.80 €
-99.973 % ↓
-32 402 637.53 €
-258.408 % ↓
31/12/2020
10 273.80 €
-73.81 % ↓
-26 937 908.84 €
-
30/09/2020
10 273.80 €
-98.697 % ↓
-21 004 321.20 €
-
31/12/2019
39 227.24 €
-
-15 173 471.57 €
-
30/09/2019
788 280.81 €
-
-15 683 425.74 €
-
30/06/2019
188 664.36 €
-
-15 944 006.72 €
-
31/03/2019
38 325 951.37 €
-
20 455 139.78 €
-
Show:
to
Mersana Therapeutics, Inc. financial report charts
Dates of Mersana Therapeutics, Inc. finance reports: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Mersana Therapeutics, Inc. is 30/06/2021. Gross profit Mersana Therapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Mersana Therapeutics, Inc. is -31 944 000 €
Mersana Therapeutics, Inc. quarterly report dates
Cost of revenue Mersana Therapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Mersana Therapeutics, Inc. is 31 955 000 € Total revenue Mersana Therapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Mersana Therapeutics, Inc. is 11 000 € Operating income Mersana Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Mersana Therapeutics, Inc. is -40 827 000 €
Net income Mersana Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Mersana Therapeutics, Inc. is -40 913 000 € Current assets Mersana Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Mersana Therapeutics, Inc. is 233 431 000 € Total assets Mersana Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Mersana Therapeutics, Inc. is 253 685 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-29 835 121.01 €
-25 594 842.73 €
-21 337 752.77 €
-15 443 392.37 €
-11 570 169.02 €
-12 008 206.57 €
-12 668 531.85 €
24 182 661.94 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
29 845 394.81 €
25 605 116.53 €
21 348 026.57 €
15 453 666.17 €
11 609 396.26 €
12 796 487.38 €
12 857 196.21 €
14 143 289.43 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
10 273.80 €
10 273.80 €
10 273.80 €
10 273.80 €
39 227.24 €
788 280.81 €
188 664.36 €
38 325 951.37 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-38 131 683.11 €
-32 326 984.98 €
-26 861 322.32 €
-20 936 140.51 €
-15 503 167.22 €
-16 151 350.73 €
-16 583 784.39 €
20 032 979.92 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-38 212 005.57 €
-32 402 637.53 €
-26 937 908.84 €
-21 004 321.20 €
-15 173 471.57 €
-15 683 425.74 €
-15 944 006.72 €
20 455 139.78 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
38 141 956.92 €
32 337 258.79 €
26 871 596.12 €
20 946 414.31 €
15 542 394.46 €
16 939 631.53 €
16 772 448.76 €
18 292 971.45 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
218 020 352.24 €
216 638 992.86 €
241 509 065.56 €
256 783 407.19 €
94 636 660.13 €
107 124 933.45 €
122 926 974.91 €
131 759 642.69 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
236 937 223.67 €
231 544 411.60 €
255 349 744.82 €
270 974 329.70 €
100 441 358.26 €
113 623 580.21 €
130 180 279.12 €
139 525 703.02 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
212 376 299.02 €
213 349 508.26 €
238 253 204.31 €
253 049 347.15 €
58 234 711.68 €
54 354 016.47 €
108 534 312.29 €
128 216 114.98 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
22 480 946.74 €
20 906 253.09 €
22 338 047.49 €
21 103 323.29 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
27 293 755.99 €
26 721 225.02 €
28 830 156.38 €
23 644 688.31 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
27.17 %
23.52 %
22.15 %
16.95 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
182 605 622.77 €
184 870 529.12 €
213 029 152.43 €
236 585 112.46 €
73 147 602.28 €
86 902 355.19 €
101 350 122.75 €
115 881 014.70 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-11 745 757.63 €
-15 208 962.89 €
-13 259 742.45 €
-23 057 213.63 €
Last revenue report of Mersana Therapeutics, Inc. was 30/06/2021. According to last financial report total revenue in Mersana Therapeutics, Inc. was 10 273.80 Euro and changed by -94.554% since last year. Net income in Mersana Therapeutics, Inc. was -38 212 005.57 € in last quartal, net income changes to -258.408%.
Current cash Mersana Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Mersana Therapeutics, Inc. is 227 388 000 €
Mersana Therapeutics, Inc. stocks data
0M4.F stock price
Mersana Therapeutics, Inc. stock price today, 0M4.F stock quote.
